CLEVELAND, OH. – March 12, 2025 PrivateEquityCXO and Falcon Partners have announced 2025’s Top 50 Private Equity Firms who best enable their portfolio company executives to drive maximum returns. Winners are determined through data collected from thousands of sponsor-backed executives highlighting their experiences and rating funds using PE-CXO’s Nine Dimensions of Governance Fit®, a… Read more »
FDA Approves MIUDELLA®, the First Hormone-Free Copper Intrauterine System (IUS) in the U.S. in Over 40 Years, from Sebela Women’s Health Inc. ROSWELL, GA, February 24, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of MIUDELLA® (copper intrauterine system) for… Read more »
ROSWELL, Ga, DUBLIN and HAMILTON, Bermuda, Jan. 28, 2025 — Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SL1009, Sodium Dichloroacetate Oral Solution (DCA). DCA will be used with a proprietary genetic test to treat an orphan pediatric mitochondrial disease, Pyruvate… Read more »